CPC Biotech is an Italian SME founded in 2006 and today represents one of the most important world player in the market of analytical enzymes.
Our innovative products, built up in the R&D labs from gene cloning up to their final formulations, are unique in the global market and some of them are also covered by trade mark license.
Exclusive supply agreement signed with big international group like Merck-Millipore represents one of our last evidence of the high-quality standard offered by CPC Biotech.
At the beginning of 2018, CPC Biotech acquired the business unit of Neomed s.r.l. related to the production of ready to use microbiological soils . Thanks to this acquisition, CPC Biotech has further consolidated its leading role in the pharmaceutical sector, as it is now able to offer both enzymes and soils added with the enzymes themselves.
The hallmark of CPC Biotech is its commitment to the development and optimization of large scale enzyme productions dedicated to sustainable industrial manufacturing of bulk chemicals.
CPC Biotech has its main expertise in fed batch fermentation technology and scale up studies for the production of recombinant enzymes at industrial level. The company establishes itself not only as a partner for chemical and pharmaceutical companies but also as an opportunity for academic labs to develop their enzymes up to commercial scale.
CPC Biotech is your ideal partner in manufacturing enzymes for diagnostic kits, biosensors and other medium-small scale productions with particular attention in price to quality optimization.